TOGA (University of Virginia)

Status: Currently enrolling

ClinicalTrials.gov Identifier: NCT01782989

TOGA: A randomized, double masked, placebo controlled study evaluating ORACEA in subjects with Geographic Atrophy secondary to Non-Exudative Age-related Macular Degeneration.

Condition: Geographic Atrophy

Study Type: Interventional

Duration: 30 months

Eligibility:

  • Ages: 55 years and older
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information on this study, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.